AI/ML-enabled medical device firms paid $39.7 million for radiology devices from 2017–2023, raising transparency concerns.
Key Details
- 1AI/ML-enabled medical device developers paid $39.7M for radiology devices over seven years.
- 2Total industry payments to healthcare entities reached $179M in the same period; only cardiovascular devices saw more ($59.4M).
- 3Researchers identified 846 FDA-listed AI/ML-enabled medical devices, but only 79 (9.3%) disclosed payment data.
- 4Annual payments rose from $17.3M in 2017 to $24.6M in 2023, with general payments doubling from $6.6M to $13.3M.
- 5The number of physician and hospital payment recipients more than doubled, but most manufacturers reported no payments.
- 6Study suggests underreporting may occur due to differing device clearance, reimbursement, and classification pathways.
Why It Matters
Financial incentives from AI device manufacturers may influence adoption and promotion decisions in radiology, underlining the importance of transparency. Calls for modernized disclosure requirements could affect radiology-AI industry practices and regulatory oversight.
Source
AuntMinnie
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
New Rubric Enhances Safety of AI-Generated Radiology Summaries
Researchers developed a five-factor rubric to assess the safety and quality of AI-generated, patient-friendly radiology report summaries.
•Radiology Business
AI Model Surpasses Radiologists in Detecting Subtle Hip Fractures
A new AI model outperformed radiologists in identifying difficult-to-detect femoral neck fractures on radiographs.